Irish-run Open Orphan reports strong growth as revenue rises

Cash and cash equivalents for the group were £15.7m by the end of 2021, a decline from £19.2m by the end of 2020.
Dublin-based pharmaceutical services firm Open Orphan recorded revenues of £39m during the 2021 financial year, it announced today.
The firm saw its revenue increase by 76%, from £22.2m in 2020.